Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M

Am J Geriatr Psychiatry

January 2020

← Back to Publications